Laparoscopic Staging for Stage III Gastric Cancer
NCT: NCT07533825 · ENROLLING_BY_INVITATION
Brief Summary
This study aims to determine, through a multicenter randomized controlled design, the impact of precision treatment guided by laparoscopic staging on overall survival (OS), surgical conversion rate, and peritoneal metastasis rate in patients with clinical stage III gastric cancer, thereby providing evidence for precision staging and treatment decision-making.
Frequently Asked Questions
What is Laparoscopic Staging for Stage III Gastric Cancer?
Laparoscopic Staging for Stage III Gastric Cancer is a clinical trial registered under NCT07533825. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT07533825?
The current status of NCT07533825 (Laparoscopic Staging for Stage III Gastric Cancer) is: ENROLLING_BY_INVITATION.
When did Laparoscopic Staging for Stage III Gastric Cancer start?
Laparoscopic Staging for Stage III Gastric Cancer started on 2025-02-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.